ENUREV

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Italy, Lithuania, Poland, South Africa, Spain.

Active ingredients

The drug ENUREV contains one active pharmaceutical ingredient (API):

1	Glycopyrronium bromide UNII A14FB57V1D - GLYCOPYRRONIUM
	Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways.
	Read more about Glycopyrronium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BB06		R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1595875, 1595886, 1595897, 1595909, 1595910, 1595921, 1718490
ES	Centro de información online de medicamentos de la AEMPS	112789003
IT	Agenzia del Farmaco	042304016, 042304028, 042304030, 042304042, 042304055, 042304067, 042304079, 042304081
LT	Valstybinė vaistų kontrolės tarnyba	1067952, 1067953, 1067954, 1067955, 1067956, 1067957, 1076816, 1076817
PL	Rejestru Produktów Leczniczych	100309639
ZA	Health Products Regulatory Authority	47/10.2.1/0119